Adiponectin mRNA in adipose tissue and its association with metabolic risk factors in postmenopausal obese women

Hormones

Volumn 12, Issue 1, 2013, Pages 119-127

  Sadashiv, ^a   Tiwari, Sunita ^a   Paul, Bhola Nath ^b   Kumar, Sandeep ^a   Chandra, Abhijit ^a   Dhananjai, S ^a   Negi, Mahendra Pal Singh ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Indian Institute of Toxicological Research   (India)

^c Institute for Data Computing and Training   (India)

Author keywords

Adiponectin; Adipose tissue; BMI; HOMA; mRNA; Obesity; SAT; VAT

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PATIENT ASSESSMENT; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 84876245051     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401293     Document Type: Article

References (57)

1. Kahn BB, Flier JS, 2000 Obesity and insulin resistance. J Clin Invest 106: 473-481.
2. Bergman RN, Ader M, 2000 Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11: 351-356.
3. Saltiel AR, Kahn CR, 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
4. Berg AH, Combs TP, Scherer PE, 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89.
5. Matsuzawa Y, Funahashi T, Nakamura T, 1999 Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892: 146-154.
6. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, 2004 Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
7. Arita Y, Kihara S, Ouchi N, et al, 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
8. Yang WS, Lee WJ, Funahashi T, et al, 2002 Plasma adiponectin levels in overweight and obese Asians. Obes Res 10: 1104-1110.
9. Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R, 2005 Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31: 55-62.
10. Hotta K, Funahashi T, Arita Y, et al, 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
11. Weyer C, Funahashi T, Tanaka S, et al, 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
12. Matsubara M, Maruoka S, Katayose S, 2002 Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764-2769.
13. Fox CS, Massaro JM, Hoffmann U, et al, 2007 Abdominal visceral and subcutaneous adipose tissue compartments association with metabolic risk factors in the framingham heart study. Circulation 116: 39-48.
14. Poirier P, Després JP, 2003 Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 23: 161-169.
15. Klein S, 2004 The case of visceral fat: argument for the defense. J Clin Invest 113: 1530-1532.
16. Goodpaster BH, Krishnaswami S, Resnick H, et al, 2003 Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26: 372-379.
17. Kanaya AM, Harris T, Goodpaster BH, Tylavsky F, Cummings SR, 2004 Health, Aging, and Body Composition (ABC) Study: Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 27: 1375-1380.
18. Matsuzawa Y, 2006 Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3: 35-42.
19. Wajchenberg BL, 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738.
20. Yatagai T, Nagasaka S, Taniguchi A, et al, 2003 Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274-1278.
21. Bacha F, Saad R, Gungor N, Arslanian SA, 2004 Adiponectin in youth relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 27: 547-552.
22. Saijo Y, Kiyota N, Kawasaki Y, et al, 2004 Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 6: 249-258.
23. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD, 2004 Splanchnic lipolysis in human obesity. J Clin Invest 113: 1582-1588.
24. Sam S, Haffner S, Davidson MH, et al, 2008 Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes 57: 2022-2027.
25. Arner P, 1998 Not all fat is alike. Lancet 351: 1301-1302.
26. Yang WS, Chen MH, Lee WJ, 2003 Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord 27: 896-900.
27. Fisher FM, McTernan PG, Valsamakis G, et al, 2002 Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res 34: 650-654.
28. Lihn AS, Ostergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O, 2002 Adiponectin mRNA expression in subcutaneous adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 284: E443-E448.
29. Bjorntorp P, 1992 Metabolic abnormalities in visceral obesity. Ann Med 24: 3-5.
30. Fried SK, Bunkin DA, Greenberg AS, 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Clin Endocrinol Metab 83: 847-850.
31. Lu HL, Wang HW, Wen Y, Zhang MX, Lin HH, 2006 Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 12: 1747-1751.
32. Altomonte J, Harbaran S, Richter A, Dong H, 2003 Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 52: 958-963.
33. The World Health Report 2002 Reducing Risks, Promoting Healthy Life World Health Organization, Geneva.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
35. Statnick MA, Beavers LS, Conner LJ, et al, 2000 Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1: 81-88.
36. Cnop M, Havel PJ, Utzschneider KM, et al, 2003 Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469.
37. Fruebis J, Tsao TS, Javorschi S, et al, 2001 Proteolytic cleavage product of 30-kDa adipocyte complementrelated protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98: 2005-2010.
38. Yamauchi T, Kamon J, Minokoshi Y. et al,2002 Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
39. De Las Heras J, Lee S, Bacha F, et al, 2011 Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr 76: 379-385.
40. Kouidhi S, Jarboui S, Marrakchi R, et al, 2011 Adiponectin expression and metabolic markers in obesity and type 2 diabetes. J Endocrinol Invest 34: e16-23.
41. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B, 2004 Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinology 219: 9-15.
42. Fain JN, Madan AK, Hiler ML, 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273-2282.
43. Degawa-Yamauchi M, Moss KA, Bovenkerk JE, et al, 2005 Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 13: 662-669.
44. Fredriksson J, Carlsson E, Orho-Melander M, Groop L, Ridderstråle M, 2006 A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int J Obes (Lond) 30: 226-232.
45. Hu E, Liang P, Spiegelman BM, 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703.
46. Kern PA, Di Gregorio GB, Lu T, 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779-1785.
47. Abbasi F, Chu JW, Lamendola C, et al, 2004 Discrimination between obesity insulin resistance relationship with adiponectin. Diabetes 53: 585-590.
48. Motoshima H, Wu X, Sinha MK, et al, 2002 Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone. J Clin Endocrinol Metab 87: 5662-5667.
49. Coughlin CC, Finck BN, Eagon JC, et al, 2007 Effect of Marked Weight Loss on Adiponectin Gene Expression and Plasma Concentrations. Obesity 15: 640-645.
50. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE, 2001 The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
51. Fruebis J, Tsao TS, Javorschi S, et al, 2001 Proteolytic cleavage product of 30-kDa adipocyte complementrelated protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 98: 2005-2010.
52. Yamauchi T, Kamon J, Waki H, et al, 2001 The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
53. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ, 2003 Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52: 1355-1363.
54. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L, 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108: 1875-1881.
55. Wang C, Mao X, Wang L, et al, 2007 Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase mediated serine phosphorylation of IRS-1. J Biol Chem 282: 7991-7996.
56. Hotta K, Funahashi T, Bodkin NL, et al, 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133.
57. Yang WS, Lee WJ, Funahashi T, et al, 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819.